| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |